Further studies are required to investigate the anti-osteogenic and anti-chondrogenic mechanism of DNMT1 in detail, and to evaluate the effectiveness of DNMT1-specific inhibitors, such as MG98 (Amato et al., 2012), in the prevention and treatment of age-related bone loss in animal models. The gene discussed is DNMT1; the disease is age.